Oportuzumab monatox Completed Phase 2 Trials for Bladder Cancer / Bladder Neoplasm Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00462488Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ